27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
The multistate vertically integrated cannabis brand and delivery company DionyMed Brands Inc (OTC:DYMEF) reported Friday with first-quarter results which fell short of expectations, but the company is set up for a "strong" 2020, according to Canaccord Genuity.
The Analyst
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Bobby Burleson maintained a Speculative Buy rating on DionyMed's Canada-listed stock with an unchanged CA$6 ($4.46) price target.
Need more cannabis news? Check out all of our coverage here.
The Thesis
DionyMed reported revenue of CA$14.4 million and an EBITDA loss of CA$6.5 million in the first quarter, missing expectations of CA$19.3 million in revenue and a CA$4.8-million EBITDA loss, Burleson said in a Sunday note. (See his track record here.)
Revenue would have been CA$19.4 million on a pro-forma basis if the figure had included around CA$5 million of products that were processed that the company could not reflect as revenue due to contract terms that are being amended, the analyst said.
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
The earnings report also showed strong adoption of the Chill business, which is operating at a CA$10.3-million revenue run rate, he said.
As DionyMed continues to grow its business, it should translate to a notable margin uptick for the direct-to-consumer business and the company as a whole, Burleson said.
The DTC business should reach a run rate that would fully replace Eaze in 2020 at "much healthier" margins, the analyst said.
The wholesale distribution business should see improvements in margins throughout 2019 and into 2020 as partnerships and the company's own brands take a greater share, according to Canaccord.
Price Action
DionyMed shares were down 13.7 percent at $1.48 at the time of publication Monday.
Related Links:
DionyMed Brands To Buy Los Angeles Cannabis Operations From MMAC
KushCo, DionyMed And More Investor Presentations From The Cannabis Capital Conference
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.